太平洋证券股份有限公司 关于万达信息股份有限公司 2024 年定期现场检查报告 | 保荐机构名称：太平洋证券股份有限公司 被保荐公司简称：万达信息 | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 保荐代表人姓名：欧阳凌 联系电话：021-61376535 | | | | | | | | | | | 保荐代表人姓名：敬启志 联系电话：010-88321538 | | | | | | | | | | | 现场检查人员姓名：欧阳凌、祝灵 | | | | | | | | | | | 现场检查对应期间：2023 年 7 月 1 日—2023 年 12 月 31 日、2024 年 1 | | | | | | | 月 | 1 | 日— | | 月 | 2024 年 6 | 30 | 日 | | | | | | | | 现场检查时间： 2024 年 月 24 日—2024 年 9 月 27 日、2024 年 9 月 | | | | | 9 | | | 30 | 日、 | | 10 月 8 年 10 月 11 ...

太平洋证券股份有限公司 关于万达信息股份有限公司 2024 年持续督导期培训的报告 太平洋证券股份有限公司（以下简称"太平洋证券"或"保荐机构"）作为 万达信息股份有限公司（以下简称"万达信息"或"公司"）持续督导工作的保 荐机构，根据《深圳证券交易所上市公司自律监管指引第 13 号——保荐业务》 的要求，于 2024 年 9 月 24 日对万达信息进行了 2024 年持续督导培训。现报告 如下： 一、本次培训基本情况 （一）保荐机构：太平洋证券 1 证了本次培训的顺利开展。通过此次培训，万达信息部分董事、监事、高级管理 人员等对上市公司规范运作的法律法规体系有了更系统、全面的认识，更加深入 理解上市公司规范运作的重要性，对上市公司募集资金管理、募集资金使用及相 关信息披露要求有了更全面的了解，有助于公司进一步提高信息披露质量和规范 运作水平。本次培训达到预期效果。 （三）培训时间：2024 年 9 月 24 日 （四）培训人员：欧阳凌、敬启志 （五）培训对象：万达信息董事、监事、高级管理人员等。 二、本次培训内容 本次培训中，太平洋证券保荐代表人欧阳凌和敬启志先生根据《深圳证券交 易所创业板股票上市规则（2 ...

证券代码：300168 证券简称：万达信息 公告编号：2024-050 万达信息股份有限公司 一、本次诉讼的基本情况 2023 年 7 月 21 日，公司收到法院送达的《应诉通知书》[（2023）沪 7101 民初 1399 号]《民事起诉状》等相关材料，载明案件情况及诉讼请求如下： 关于重大诉讼事项的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 重要内容提示： 1、案件所处的诉讼阶段：一审判决； 2、上市公司所处的当事人地位：被告； 3、涉案的金额：人民币 2.8 亿元； 4、诉讼结果：驳回原告上海万豪投资有限公司管理人（以下简称"原告"） 的诉讼请求； 5、对上市公司损益产生的影响：本次判决结果对公司本期利润或期后利 润不产生影响。 2024 年 9 月 30 日，万达信息股份有限公司（以下简称"公司"或"被告"） 收到上海铁路运输法院（以下简称"法院"）送达的《民事判决书》[（2023） 沪7101民初1399号]，载明法院驳回原告的诉讼请求，现将诉讼情况公告如下： （一）案件事实及纠纷起因 2019 年 12 月 6 日，公司收到上海万豪投 ...

观韬中茂律师事务所 GUANTAO LAW FIRM 地址：上海市长宁区仙霞路 99 号尚嘉中心 12 层、22 层（200051） Add: 12F&22F，L'Avenne No.99 XianXia Rd,Changning District,Shanghai,PRC 电话 Tel: +86 21 23563298 传真 Fax: +86 21 23563299 网址 Website：http://www.guantao.com 邮箱 Email: guantaosh@guantao.com 北京观韬中茂（上海）律师事务所 关于 万达信息股份有限公司 2024年第四次临时股东大会 之 法律意见书 2024年9月23日 北京 上海 广州 深圳 香港 天津 杭州 苏州 成都 厦门 大连 济南 西安 武汉 南京 福州 郑州 悉尼 多伦多 Beijing︱Shanghai︱Guangzhou︱Shenzhen︱Hong Kong︱Tianjin︱Hangzhou︱Suzhou︱Chengdu︱Xiamen︱Dalian︱Jinan︱Xi'an︱Wuhan︱Nanjing︱Fuzhou︱Zhengzhou︱Syd ...

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东大会未出现否决议案的情形； 2、本次股东大会不涉及变更以往股东大会已通过的决议； 3、截至本次股东大会股权登记日，万达信息股份有限公司（以下简称"公 司"）总股本为1,441,777,126股。 一、会议召开和出席情况 证券代码：300168 证券简称：万达信息 公告编号：2024-049 万达信息股份有限公司 2024年第四次临时股东大会决议公告 现场会议召开时间为 2024 年 9 月 23 日 15:00，会议地点为上海市静安区北 京西路 968 号 32 楼会议室；网络投票的时间为 2024 年 9 月 23 日，其中，通过 深圳证券交易所交易系统进行网络投票的时间为 2024 年 9 月 23 日的交易时间， 即 9:15-9:25，9:30-11:30 和 13:00-15:00；通过深圳证券交易所互联网投票系统投 票的时间为 2024 年 9 月 23 日 9:15-15:00。 参加本次股东大会表决的股东或经股东授权的代理人共 277 名，所持有表决 权的股份数 495,3 ...

证券代码：300168 证券简称：万达信息 公告编号：2024-048 万达信息股份有限公司 关于召开2024年第四次临时股东大会的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 万达信息股份有限公司（以下简称"公司"）第八届董事会第十次会议决定 于2024年9月23日召开公司2024年第四次临时股东大会。本次股东大会将采取现 场投票和网络投票相结合的方式，现将有关事项提示如下： 一、召开会议的基本情况 2、股东大会的召集人：万达信息股份有限公司董事会。2024年8月28日公司 第八届董事会第十次会议决定于2024年9月23日召开公司2024年第四次临时股东 大会。 3、本次股东大会会议召开符合有关法律、行政法规、部门规章、规范性文 件和公司章程等的规定。 4、会议召开的日期、时间： （1）现场会议召开时间为：2024年9月23日（星期一）15:00； （2）网络投票时间：2024年9月23日，其中，通过深圳证券交易所交易系统 进行网络投票的时间为2024年9月23日的交易时间，即9:15-9:25，9:30-11:30和 13:00-15:00； ...

太平洋证券股份有限公司 关于万达信息股份有限公司 2024 年半年度持续督导跟踪报告 | 保荐机构名称：太平洋证券股份有限公司 | 被保荐公司简称：万达信息 | | --- | --- | | 保荐代表人姓名：欧阳凌 | 联系电话：021-61376535 | | 保荐代表人姓名：敬启志 | 联系电话：010-88321538 | 一、保荐工作概述 | 事项 | 存在的问题 | 采取的措施 | | --- | --- | --- | | 1.信息披露 | 无 | 不适用 | | 2.公司内部制度的建立和 执行 | 无 | 不适用 | | 3．"三会"运作 | 无 | 不适用 | | 4.控股股东及实际控制人 变动 | 无 | 不适用 | | 5.募集资金存放及使用 | 无 | 不适用 | | 6.关联交易 | 无 | 不适用 | | 7.对外担保 | 无 | 不适用 | | 8.收购、出售资产 | 无 | 不适用 | | 9.其他业务类别重要事项 （包括对外投资、风险投 | 无 | 不适用 | 2 | 事项 | 存在的问题 | 采取的措施 | | --- | --- | --- | | 资、委托理财、财务资助 ...

万达信息股份有限公司 章 程 二〇二四年八月 1 | | | | 第一章 | 总则 3 | | --- | --- | | 第二章 | 经营宗旨和范围 4 | | 第三章 | 股份 7 | | 第一节 股份发行 7 | | | 第二节 股份增减和回购 | 8 | | 第三节 股份转让 10 | | | 第四章 | 股东和股东大会 12 | | 第一节 股东 12 | | | 第二节 股东大会的一般规定 | 14 | | 第三节 股东大会的召集 | 18 | | 第四节 股东大会的提案与通知 | 20 | | 第五节 股东大会的召开 | 22 | | 第六节 股东大会的表决和决议 | 25 | | 第五章 | 董事会 30 | | 第一节 董事 30 | | | 第二节 董事会 33 | | | 第三节 独立董事 37 | | | 第四节 董事会秘书 | 42 | | 第五节 专门委员会 | 42 | | 第六章 | 党组织 43 | | 第七章 | 经理及其他高级管理人员 43 | | 第八章 | 监事会 45 | | 第一节 监事 45 | | | 第二节 监事会 46 | | | 第九章 | 财务会计制度 ...

一、 募集资金基本情况 万达信息股份有限公司 2024年半年度 募集资金存放与使用情况专项报告 万达信息股份有限公司 2024年半年度募集资金存放与使用情况专项报告 根据中国证券监督管理委员会《上市公司监管指引第 2 号——上市公司募集资金管理 和使用的监管要求》（证监会公告〔2022〕15 号）、《深圳证券交易所上市公司自律监管 指引第 2 号——创业板上市公司规范运作》以及《深圳证券交易所创业板上市公司自律监 管指南第 2 号——公告格式》的相关规定，万达信息股份有限公司（以下简称"公司"或 "万达信息"）就 2024 年半年度募集资金存放与使用情况作如下专项报告： (一) 实际募集资金金额、资金到位情况 根据中国证券监督管理委员会出具的《关于同意万达信息股份有限公司向特定对象发 行股票注册的批复》（证监许可[2022]1689 号），公司向特定对象发行人民币普通股 股票（A 股）255,607,229 股，面值为每股人民币 1 元，发行价格为每股人民币 7.74 元，截至 2023 年 1 月 9日止，公司本次向特定对象发行股票（以下简称"本次发行"） 募集资金总额为人民币 1,978,399,952. ...

Financial Performance - The company's operating revenue for the first half of 2024 was ¥922,974,705.71, a decrease of 34.44% compared to ¥1,407,901,421.44 in the same period last year[10]. - The net loss attributable to shareholders for the first half of 2024 was ¥365,589,137.67, representing a significant increase in loss of 277.22% from a loss of ¥96,916,860.22 in the previous year[10]. - The basic earnings per share for the first half of 2024 was -¥0.2538, a decline of 277.68% compared to -¥0.0672 in the same period last year[10]. - The total assets at the end of the reporting period were ¥6,830,994,807.18, down 1.93% from ¥6,965,125,165.06 at the end of the previous year[10]. - The net assets attributable to shareholders decreased by 15.67%, from ¥2,327,847,444.24 to ¥1,963,134,858.66[10]. - The net cash flow from operating activities was -¥633,139,646.53, an improvement of 12.29% compared to -¥721,859,378.83 in the previous year[10]. - The company reported a total of ¥36,672,128.76 in non-recurring gains and losses for the reporting period[15]. - The weighted average return on net assets was -17.04%, a decrease of 13.99% from -3.05% in the previous year[10]. Business Operations and Strategy - In the first half of 2024, the company expanded its core business in smart healthcare, covering over 30 provinces and municipalities, serving more than 600 million people[18]. - The company actively participated in the construction of smart healthcare systems, achieving significant results in information technology applications across various medical centers, including the completion of a project for Zhengzhou Children's Hospital[22]. - The company has established a comprehensive data service system for urban governance, enhancing its capabilities in digital governance and service delivery across multiple sectors, including market regulation and urban safety[23]. - The company is focusing on the integration of smart medical insurance and drug management, successfully implementing projects in major cities such as Shanghai and Guangxi[20]. - The company has made strides in the development of smart medical platforms, including the construction of a unified data standard and integrated service systems for regional medical centers[22]. - The company is leveraging its experience in urban information technology to support the digital transformation of government services, contributing to the construction of a data-driven digital city framework[24]. - The company has actively engaged in the innovation of health data applications, establishing a leading position in the data governance and asset application market within the healthcare sector[19]. - The company has successfully expanded its market presence in regions such as Heilongjiang, Hainan, and Hunan, enhancing its customer base and business scope[19]. - The company is committed to advancing the integration of traditional Chinese medicine into digital healthcare projects, with several successful bids for modernization initiatives[22]. - The company is focused on enhancing its technological capabilities and project experience to support the implementation of national healthcare policies and standards[20]. Financial Management and Investments - The company plans not to distribute cash dividends or issue bonus shares for the reporting period[1]. - The company invested ¥2.72 million during the reporting period, a decrease of 79.03% compared to the previous year[72]. - The total amount of raised funds was ¥197.84 million, with ¥5.42 million invested during the reporting period[74]. - The balance of unused raised funds as of June 30, 2024, was ¥826.34 million[74]. - The company has committed a total of 235,000 for the future public health digital management project, with an investment progress of 46.09% as of the end of the reporting period[75]. - The big data-based disease scoring payment project has a total commitment of 115,000, with an investment progress of 37.68%[75]. - The intelligent medical data capability open service platform project has a total commitment of 111,113, with an investment progress of 3.91%[75]. - The medical operation and IoT management platform innovation project has a total commitment of 69,000, with an investment progress of 48.22%[75]. - The citizen cloud open service platform has a total commitment of 211,000, with an investment progress of 55.40%[75]. - The future community operation service platform has a total commitment of 517,500, with an investment progress of 39.81%[75]. Market and Competitive Landscape - The company is actively collaborating with major financial institutions to expand its government service projects, enhancing comprehensive capabilities in urban governance[25]. - The company is leveraging advanced technologies such as IoT, big data, and AI to improve urban governance efficiency and create new governance models[25]. - The company is focusing on the integration of digital technology in transportation management, enhancing traffic monitoring and service delivery across urban areas[28]. - The ICT business leverages innovative technologies such as cloud computing, big data, and artificial intelligence to drive digital transformation and enhance project management capabilities[32]. - In 2024, the company aims to deepen its focus on government and enterprise digital transformation, particularly in the healthcare sector, to expand market share[33]. - The company has become a key contractor for digital governance projects in Shanghai, focusing on urban management and grassroots governance digitalization[38]. - The company has established strategic partnerships to enrich its product offerings and cover a wider range of health management scenarios[46]. - The company has formed strategic partnerships with clients such as the Shanghai Transportation Commission and Zhejiang Transportation Department, demonstrating its long-term commitment to the transportation management sector[50]. Research and Development - The company plans to focus on R&D investments to maintain technological leadership and core product competitiveness[87]. - The company aims to expand its market presence in key regions such as East China, South China, Southwest, North China, and Central China[87]. - The company faced risks from intensified industry competition due to rapid advancements in AI, big data, and cloud computing technologies[87]. - The company is committed to adapting to market changes through continuous innovation in product and service offerings[87]. - The company emphasizes the need for emerging technologies such as artificial intelligence, big data, and the Internet of Things to support its projects, highlighting the risks associated with rapid technological changes that could impact profitability and market share[89]. - The company plans to enhance its R&D capabilities by focusing on the commercial viability of technological achievements to mitigate R&D risks[89]. Shareholder and Governance - The company held its first temporary shareholders' meeting on January 16, 2024, with a participation rate of 36.11%[93]. - The company granted 2,540,115 restricted shares at a price of RMB 4.08 per share to 81 incentive recipients as part of its 2022 restricted stock incentive plan[97]. - The company repurchased 1,391,565 restricted shares, with a repurchase price of RMB 4.08 and RMB 4.17 per share, due to employee departures and unmet vesting conditions[97]. - The number of incentive recipients for the 2022 restricted stock incentive plan will be adjusted to 74 after the repurchase and cancellation of shares[97]. - The company is committed to maintaining a focus on industry dynamics and market demands to ensure its R&D efforts align with current trends[89]. - The company held 4 shareholder meetings, 4 board meetings, and 1 supervisory board meeting during the reporting period[100]. Legal and Compliance - The company is involved in two significant lawsuits, with one case involving a claim of RMB 280 million and another involving RMB 1.705 billion, both of which are currently in court proceedings[105]. - The company reported a total of 6,592.38 million yuan in sales from related party transactions during the reporting period[111]. - The company purchased commercial insurance from related parties for a total of 303.93 million yuan[110]. - The company also engaged in procurement of goods and services from related parties amounting to 191.51 million yuan[110]. - The company has no significant litigation or arbitration cases during the reporting period, with a total amount involved in ongoing cases of 3,186.74 million yuan[106]. - The company reported no penalties or rectifications during the reporting period[107]. Assets and Liabilities - The total assets of Wanda Information Co., Ltd. decreased from CNY 6,965,125,165.06 at the beginning of the period to CNY 6,830,994,807.18 at the end of the period, representing a decline of approximately 1.93%[141]. - Current assets decreased from CNY 3,801,678,195.52 to CNY 3,718,000,386.40, a reduction of about 2.20%[141]. - Cash and cash equivalents decreased from CNY 1,604,471,786.19 to CNY 1,320,376,491.20, a decline of approximately 17.67%[141]. - Accounts receivable increased from CNY 496,998,247.34 to CNY 525,291,136.23, an increase of about 5.20%[141]. - Inventory increased from CNY 735,677,242.49 to CNY 782,777,289.81, reflecting a growth of approximately 6.39%[141]. - Short-term borrowings rose significantly from CNY 1,587,959,700.00 to CNY 2,086,146,900.00, an increase of about 31.50%[142]. - The company's non-current assets decreased from CNY 3,163,446,969.54 to CNY 3,112,994,420.78, a reduction of about 1.59%[142]. - The total liabilities increased from CNY 3,200,000,000.00 to CNY 3,300,000,000.00, indicating a rise of approximately 3.13%[142]. Financial Reporting and Standards - The company follows the accounting standards set by the Ministry of Finance, ensuring the financial statements reflect true and complete financial conditions[171]. - The company has a business cycle of 12 months, aligning with its accounting period[173]. - The company has a significant bad debt provision for receivables exceeding 500,000 RMB, indicating a focus on credit risk management[172]. - The financial report was approved by the board of directors on August 28, 2024, ensuring compliance with regulatory requirements[170]. Risk Management - The company assesses expected credit losses based on historical credit loss experience, current conditions, and future economic forecasts, categorizing financial instruments into several groups for loss provisioning[193]. - For accounts receivable aged within 3 months, the expected credit loss rate is 0.00%, while for those aged 4 months to 1 year, the rate is 3.00%[195]. - The expected credit loss rate increases to 100.00% for accounts receivable aged over 5 years, indicating a significant risk of default[198]. - The company evaluates credit risk changes at each balance sheet date, considering a significant increase in credit risk if overdue by more than 30 days[196].